Organization Profile

You just read:

OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Aug 07, 2012, 09:30 ET